Toxoplasmosis in patients with hematologic malignancies. 2015

Ashish Chintakuntlawar, and Michael Kidd, and Aref Al-Kali, and Walter Wilson, and Carrie A Thompson
Division of Hematology/Department of Internal Medicine.

UI MeSH Term Description Entries
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069283 Rituximab A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS. CD20 Antibody, Rituximab,GP2013,IDEC-C2B8,IDEC-C2B8 Antibody,Mabthera,Rituxan,IDEC C2B8,IDEC C2B8 Antibody,Rituximab CD20 Antibody
D000069461 Bendamustine Hydrochloride A nitrogen mustard compound that functions as an ALKYLATING ANTINEOPLASTIC AGENT and is used in the treatment of CHRONIC LYMPHOCYTIC LEUKEMIA and NON-HODGKIN'S LYMPHOMA. Bendamustin,Bendamustine,Cytostasan,IMET 3393,Ribomustin,Treanda,Zimet 3393,Hydrochloride, Bendamustine
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D014122 Toxoplasma A genus of protozoa parasitic to birds and mammals. T. gondii is one of the most common infectious pathogenic animal parasites of man. Toxoplasma gondii,Toxoplasma gondius,Toxoplasmas,gondius, Toxoplasma
D016781 Toxoplasmosis, Cerebral Infections of the BRAIN caused by the protozoan TOXOPLASMA gondii that primarily arise in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES (see also AIDS-RELATED OPPORTUNISTIC INFECTIONS). The infection may involve the brain diffusely or form discrete abscesses. Clinical manifestations include SEIZURES, altered mentation, headache, focal neurologic deficits, and INTRACRANIAL HYPERTENSION. (From Joynt, Clinical Neurology, 1998, Ch27, pp41-3) Cerebral Toxoplasmosis,Intracranial Toxoplasmosis,Neurotoxoplasmosis,Toxoplasmosis, Central Nervous System,Central Nervous System Toxoplasmosis,Toxoplasmoses, Cerebral,Toxoplasmosis, Intracranial
D019337 Hematologic Neoplasms Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES. Blood Cancer,Hematologic Malignancies,Hematopoietic Neoplasms,Hematologic Malignancy,Hematological Malignancies,Hematological Neoplasms,Hematopoietic Malignancies,Malignancies, Hematologic,Malignancy, Hematologic,Neoplasms, Hematologic,Neoplasms, Hematopoietic,Blood Cancers,Cancer, Blood,Hematologic Neoplasm,Hematological Malignancy,Hematological Neoplasm,Hematopoietic Malignancy,Hematopoietic Neoplasm,Malignancy, Hematological,Malignancy, Hematopoietic,Neoplasm, Hematologic,Neoplasm, Hematological,Neoplasm, Hematopoietic

Related Publications

Ashish Chintakuntlawar, and Michael Kidd, and Aref Al-Kali, and Walter Wilson, and Carrie A Thompson
June 2022, American journal of surgery,
Ashish Chintakuntlawar, and Michael Kidd, and Aref Al-Kali, and Walter Wilson, and Carrie A Thompson
June 1998, Journal of the Formosan Medical Association = Taiwan yi zhi,
Ashish Chintakuntlawar, and Michael Kidd, and Aref Al-Kali, and Walter Wilson, and Carrie A Thompson
January 2005, Archives of internal medicine,
Ashish Chintakuntlawar, and Michael Kidd, and Aref Al-Kali, and Walter Wilson, and Carrie A Thompson
September 2001, Onkologie,
Ashish Chintakuntlawar, and Michael Kidd, and Aref Al-Kali, and Walter Wilson, and Carrie A Thompson
March 2015, Current diabetes reports,
Ashish Chintakuntlawar, and Michael Kidd, and Aref Al-Kali, and Walter Wilson, and Carrie A Thompson
September 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Ashish Chintakuntlawar, and Michael Kidd, and Aref Al-Kali, and Walter Wilson, and Carrie A Thompson
January 1991, Reviews of infectious diseases,
Ashish Chintakuntlawar, and Michael Kidd, and Aref Al-Kali, and Walter Wilson, and Carrie A Thompson
October 2013, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Ashish Chintakuntlawar, and Michael Kidd, and Aref Al-Kali, and Walter Wilson, and Carrie A Thompson
December 1999, American journal of surgery,
Ashish Chintakuntlawar, and Michael Kidd, and Aref Al-Kali, and Walter Wilson, and Carrie A Thompson
August 2005, Critical reviews in oncology/hematology,
Copied contents to your clipboard!